查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1852894

神经外科器械市场按产品类型、最终用户、应用和手术方式划分－2025-2032年全球预测

Neurosurgery Devices Market by Product Type, End User, Application, Procedure - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，神经外科器械市场规模将达到 356.4 亿美元，复合年增长率为 13.27%。

关键市场统计数据
基准年 2024 131.5亿美元
预计年份：2025年 149.1亿美元
预测年份 2032 356.4亿美元
复合年增长率 (%) 13.27%

神经外科器械的综合发展方向，重点在于技术融合、临床应用压力、监管演变及其对策略决策的影响

随着技术创新与不断变化的医疗服务模式和日益增长的临床期望相融合，神经外科器械的研发正在加速发展。该领域如今涵盖了从生物活性移植物材料和先进植入系统到高解析度内视镜和导航平台等各个方面，这些设备能够实现精准手术。同时，临床实践正朝着微创方向发展，医疗系统在采用新技术之前，要求提供强有力的安全性、有效性和经济价值证据。这些动态正在重塑製造商和供应商的采购偏好、临床工作流程和竞争定位。

同时，法律规范和支付方的期望正将重点转向真实世界结果和上市后监测，这提升了整合资料收集和纵向临床研究的重要性。投资人也积极回应，支持那些不仅展现出技术差异化，而且具有可重复的临床效益和可靠商业化路径的公司。因此，产品蓝图的设计以模组化和互通性为核心，预计将包含与导航系统、神经刺激平台和数位临床决策支援系统的整合。

本导言为后续分析奠定了基础，该分析将临床趋势、医疗设备创新、终端用户行为以及更广泛的地缘政治和监管变化联繫起来。下文将探讨不断变化的格局、关税的营运影响、细分市场洞察、区域动态、竞争格局、可操作的建议、调查方法以及对塑造神经外科未来领导者的启示。

分析技术创新、临床实践转变、监管力度加大以及商业性结构重组等因素的融合，这些因素正在重塑神经外科器械的研发和应用。

神经外科器材领域正经历技术、临床、监管和商业性的变革。在技​​术方面，诊断成像、电磁和光学导航以及微型内视镜的进步，使外科医生能够以更高的精度进行手术，并减少周围组织的损伤。这些进步与改良的植入材料和生物佐剂相辅相成，旨在促进骨癒合和神经组织相容性，从而改善患者的长期预后。机器人辅助和人工智慧驱动的影像引导正从实验性工具转变为实用工具，能够减少手术操作的差异性，并缩短复杂手术的学习曲线。

临床上，微创手术和门诊病人治疗的兴起正在改变手术方式，并推动对能够缩短手术时间和加快术后恢復的器械和设备的需求。随着人们对神经调控机制的理解不断加深，神经刺激技术，特别是深部脑部刺激和迷走神经刺激，其适应症不断扩大，重新引起了人们的关注。同时，对病患报告结果和品质指标的日益重视，也提高了临床证据的门槛，进而影响了技术的采纳和报销。

监管和报销环境也在发生变化，监管机构要求提供更全面的上市后数据，而支付方则寻求可证明的价值，例如减少併发症、缩短住院时间和改善功能性结果。在商业方面，成熟的医疗技术公司、专业器材创新者和临床研究网络之间的合作正在加速商业化进程，同时也改变了竞争动态。总而言之，这些变化为企业带来了机会和执行风险，企业必须将产品创新与临床效用和监管要求结合。

评估关税引发的成本压力和供应链调整如何改变了神经外科器械製造商的筹资策略、产品设计选择和上市时间表

美国2025年全年累积实施的新关税政策，已在神经外科器械生态系统中引发了一系列营运和战略应对措施。依赖国际供应链的製造商正面临零件和成品到岸成本不断上涨的局面，这给其利润结构和定价策略带来了压力。为应对这项挑战，许多公司已启动短期战术措施，例如重新调整生产运作、增加关键零件的库存缓衝以及加快双源认证流程，以减少对单一战术性国的依赖。从长远来看，关税环境正促使企业重新评估其地理生产布局，并加深对将生产迁回国内或多元化至其他成本更低的生产地点的考虑。

除了直接的成本影响外，关税还影响着合作伙伴的选择、合约谈判和资金分配决策。采购团队正在重新谈判供应商合同，以纳入关税转嫁条款，并争取更优惠的前置作业时间和品质保证。策略团队正在重新审视产品设计，简化复杂的材料清单，减少对关税敏感组件的依赖，并探索既能保持临床性能又能降低成本风险的替代材料。临床和监管团队也参与其中，因为设计变更可能会引发额外的验证工作和监管申报，从而影响产品上市时间。

此外，关税引发的动态正在对临床应用时间表和医疗系统采购行为产生后续影响，因为医疗服务提供者在评估新型医疗设备时会考虑潜在的供应波动和总拥有成本。投资者和企业发展机构都在重新调整其评估模型和伙伴关係时间表，以反映日益增加的不确定性。整体而言，关税改革的累积影响正在加速供应链现代化进程，并提升具有韧性、合规性和以临床为中心的商业化策略的重要性。

以细分市场主导的临床和商业情报，将产品子类别、最终用户偏好、应用和手术类型联繫起来，有助于确定创新和市场进入策略的优先顺序。

细分市场分析揭示了不同产品类别、最终用户、临床应用和手术方法中存在的细微机会和实施需求。产品类型涵盖生物製药、内视镜、植入式器械、手术器械、导航系统和神经刺激设备。在生技药品领域，骨移植材料和生长因子正日益受到关注，凸显了对能够与宿主组织整合以降低重新置换风险的材料的需求，而开发商则优先考虑生物活性、灭菌兼容性和供应链可追溯性。内视镜分为软式内视镜和硬式内视镜，其应用模式截然不同。软式内视镜在复杂解剖结构和门诊病人手术中应用日益广泛，而硬式内视镜由于其影像稳定性，仍然是某些颅内和脊椎手术的首选。植入器械分为颅骨脊椎移植，其中颅骨植入主要包括颅骨植入和硬脑膜替代物，而脊椎移植主要包括融合器和椎弓根螺钉。这些考虑强调了植入生物相容性、模组化和易于固定的重要性，以缩短手术时间并降低併发症发生率。临床团队会对钻头、穿孔器、牵开器系统和超音波吸引器等器材进行评估，检视其人体工学、消毒週期以及与微创入路的兼容性。导航系统分为电磁导航和光学导航，需要精确的抗蚀剂精度以及与影像处理设备的互通性。神经刺激设备，包括深层脑部刺激器和迷走神经刺激设备，正透过先进的导线技术和封闭回路型编程选项不断发展，以支持不断扩大的治疗适应症。

终端使用者群体包括门诊手术中心、医院、研究机构和专科诊所。门诊手术中心对能够实现当日出院的紧凑型、经济高效的设备的需求日益增长，而医院则优先考虑能够与其现有影像和监测基础设施整合并支援复杂病例的系统。研究机构和专科诊所是早期采用者，它们提供临床证据和概念验证数据，以加速更广泛的应用。

应用领域细分包括脑肿瘤、癫痫、水脑症、运动障碍、疼痛管理和脊髓疾病。每种应用都需要不同的临床性能，从肿瘤手术中精确的切除边缘到运动和疼痛适应症中长期刺激的持久性。手术方式细分包括内视镜手术、雷射治疗、微创手术和开放性手术，手术方式决定了器械的外形规格、消毒方案和器械包。整合这些细分视角，可以突显未满足的临床需求和技术能力的交会点，以及有针对性的证据产生和商业化投资能够产生最大影响的领域。

对全球主要地区的临床基础设施、监管差异、采购行为和加速推广应用的策略路径进行区域比较评估

美洲、欧洲、中东和非洲以及亚太地区的区域动态正在明确优先事项，并塑造产业计画。在美洲，整合式医疗保健系统和先进的门诊手术中心网路正在催生对能够在各种医疗环境中展现明确经济和临床价值的医疗器材的需求。该地区的监管路径日益与上市后证据的预期相一致，要求製造商投资于註册登记和结果追踪。欧洲、中东和非洲是一个异质性区域，其采购惯例巨大，因此，希望进入该市场的製造商需要根据每个国家的卫生技术评估流程调整打入市场策略，并与当地临床倡导者合作以克服推广障碍。在亚太地区，医院基础设施的快速扩张、神经外科手术量的增长以及政府主导的医疗保健能力投资正在推动对扩充性器械解决方案和本地製造伙伴关係关係的需求。在所有地区，供应链韧性、对监管协调的承诺以及数位化整合能力正成为影响采购决策和长期伙伴关係的关键差异化因素。

跨境因素进一步加剧了区域策略的复杂性。跨境临床试验、监管等效性计画和多区域报销试点计画能够加速全球上市，但也需要对监管申报、临床证据包和培训计画进行周密协调。那些能够利用卓越中心 (COE)伙伴关係、数位化培训平台和灵活的定价结构来设计区域部署方案的製造商，将更有利于把早期临床应用转化为持续应用，并获得有利的采购条款。

策略性企业行动和伙伴关係模式揭示了整合平台、专业创新者和契约製造的选择如何影响商业化和规模化。

公司层面的行动揭示了当前竞争格局：成熟的医疗技术公司、专注于医疗器材的专业公司以及创新新兴企业都在塑造神经外科的发展轨迹中扮演着各自独特的角色。领先企业正投资于平台策略，将硬体、软体和资讯服务结合，打造整合解决方案，以减少临床差异并实现可衡量的疗效。同时，一些关键企业也在推动局部创新，例如新型生技药品、精密植入设计和新一代刺激导线，这些创新旨在解决特定的临床难题，并可能成为合作或收购的理想主要企业。

在整个生态系统中，商业化策略的重点在于支持实证医学证据产生、临床医生培训、设备运作和临床疗效的服务模式。设备製造商、影像和导航供应商以及学术中心之间的策略伙伴关係正在加速产品检验和临床医生的认可。製造合作伙伴和合约服务供应商对于扩充性也至关重要，尤其对于那些选择本地化生产以降低关税和物流风险的公司而言更是如此。此外，那些优先考虑透明定价、健全的上市后监测和清晰的互通性标准的公司，在医疗系统的采购流程中更容易取得成功。公司洞察表明，市场呈现两极化，平台型企业专注于整合解决方案，而专业创新者则致力于临床差异化。

针对产品开发、供应链韧性、证据产生和商业化等各环节的可操作性跨职能指导，确保产品能够被广泛采用并获得竞争优势。

产业领导者应采取优先排序的跨职能方法，将产品创新与实证实践、供应链韧性和以客户为中心的商业化相结合。首先，在研发週期的早期阶段就应纳入临床证据规划，确保临床试验、註册研究和真实世界资料收集能够涵盖对外科医生、支付方和采购方至关重要的终点指标。这种积极主动的方法可以缩短商业化週期，并提升报销地位。其次，应重新设计供应链策略，减少单一来源采购，并在关税风险或物流中断可能显着影响手术时间的情况下，评估区域製造或双重来源采购方案。投资于供应商资格确认和材料工程可以带来可持续的成本和品质优势。

门诊手术中心需要紧凑、经济高效的解决方案，医院追求互通性和服务可靠性，而专科诊所则优先考虑临床表现和培训。应开发模组化平台和相容的设备生态系统，以减少采购摩擦，并实现渐进式升级，而非一次性全部更换。在营运方面，应透过数位化模拟和指导模式扩展临床医生培训项目，以加快外科医生技能提升并儘早获取结果数据。监管和品质团队应透过记录上市后监测计画并建立电子资料采集流程，为迭代提交做好准备，以确保符合当地法规要求。

最后，寻求与自身能力互补的合作伙伴关係，例如先进的导航技术、生物製药生产和临床研究网络。优先考虑与高影响力机构合作进行商业性试点项目，这些机构能够产生可重复的结果，并可作为参考案例。透过实施这些建议，企业领导者可以提高产品长期应用的成功率，并在瞬息万变的神经外科器械市场中打造稳固的竞争优势。

一项透明的、混合方法的研究途径，结合了从业人员访谈、临床文献、监管审查和情境分析，得出了可靠的结论。

本摘要综合的研究途径结合了定性专家访谈、对临床医生和采购负责人的初步调查，以及对临床文献和监管文件的严谨二次分析。初步访谈包括对神经外科医生、手术室主管、医院采购专家、器械工程师和卫生经济学专家的结构化访谈，旨在了解临床优先事项和采购动态。这些观点与同行评审的临床研究、器材註册资讯和公开的监管文件进行交叉比对，以检验临床性能声明、安全性概况和上市后义务。

分析方法包括主题综合分析，用于识别关键的临床和商业性趋势；情境分析，用于评估关税变化和供应链中断对营运的影响；以及细分映射，用于将设备属性与最终用户的需求和操作流程相匹配。品质保证通讯协定确保所有结论均有多个资讯来源支持，并透过后续访谈和敏感性检查来协调相互矛盾的资讯。在处理原始资料时，我们充分考虑了伦理和合规性问题，并使用匿名化的访谈摘要结果来保护隐私，同时保留从业人员的深刻见解。

此调查方法框架整合了实践者的见解和文献证据，并透过情境规划和敏感性评估明确地解决了不确定性领域，从而支持稳健且可操作的结论。

整合策略要务和风险考量，以决定哪些组织能够在推动神经外科护理的临床应用和商业性规模化方面取得成功。

神经外科器械生态系统正处于曲折点，技术、临床需求、监管预期和地缘政治因素正在交汇融合，重塑投资和执行的优先事项。对于那些能够将差异化器械功能与严谨的证据生成、稳健的供应链以及针对特定临床和区域环境量身定制的商业化策略相结合的公司而言，机会比比皆是。反之，那些未能为关税驱动的成本波动、日益严格的监管以及对可验证疗效不断增长的需求做好准备的公司，则可能面临产品推广速度放缓和商业性回报缩水的风险。

领导者应专注于建立可互通的平台，投资于临床医生培训和真实世界证据项目，并创建能够最大限度降低中断风险的供应链。策略伙伴关係和有针对性的併购可以加速获取互补技术和临床管道，而精心的产品设计选择则可以降低医疗服务提供者的整体拥有成本。最终，在这个市场中取得成功的将是那些采用系统思维方法、将卓越的工程技术与临床检验相结合，并采用能够反映不同地区和不同类型医疗服务提供者实际情况的灵活商业化模式的组织。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 机器人辅助神经外科手术平台在精准肿瘤切除的应用日益广泛
  • 脊椎神经外科对微创内视镜工具的需求日益增长
  • 整合人工智慧成像系统以实现即时术中导航
  • 开发用于慢性深部脑部刺激的生物相容性神经植入
  • 用于靶向神经迴路控制的光遗传神经调控装置的进展
  • 可携式中磁振造影系统正变得越来越普遍，提高了手术室的效率。
  • 扩展无线穿戴式感测器的应用范围，用于术后持续神经系统监测

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章 按产品类型分類的神经外科器械市场

  • 生物
    • 骨移植
    • 生长因子
  • 内视镜检查
    • 柔性内视镜
    • 硬式内视镜
  • 植入式装置
    • 颅骨植入
      • 头骨板
      • 杜拉替代品
    • 脊椎移植
      • 融合笼
      • 椎弓骨钉
  • 装置
    • 钻头和穿孔器
    • 收缩器系统
    • 超音波吸引器
  • 导航系统
    • 电磁系统
    • 光学系统
  • 神经刺激设备
    • 深层脑部刺激器
    • 迷走神经刺激设备

第九章 神经外科器械市场（依最终用户划分）

  • 门诊手术中心
  • 医院
  • 研究所
  • 专科诊所

第十章 按应用分類的神经外科器械市场

  • 脑肿瘤
  • 癫痫
  • 水脑症
  • 运动障碍
  • 疼痛管理
  • 脊髓疾病

第十一章 依手术方式分類的神经外科器械市场

  • 内视镜手术
  • 雷射治疗
  • 微创手术
  • 开颅手术

第十二章 各地区神经外科器械市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 神经外科器械市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国神经外科器材市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Stryker Corporation
    • Johnson & Johnson
    • B. Braun Melsungen AG
    • Zimmer Biomet Holdings, Inc.
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Integra LifeSciences Holdings Corporation
    • Penumbra, Inc.
    • Globus Medical, Inc.
Product Code: MRR-E370886767D8

The Neurosurgery Devices Market is projected to grow by USD 35.64 billion at a CAGR of 13.27% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 13.15 billion
Estimated Year [2025] USD 14.91 billion
Forecast Year [2032] USD 35.64 billion
CAGR (%) 13.27%

Comprehensive orientation to neurosurgery devices highlighting technological convergence, clinical adoption pressures, regulatory evolution and implications for strategic decision-making

Neurosurgery device development is advancing at an accelerated pace as technological innovation converges with changing care delivery models and heightened clinical expectations. The field now spans a spectrum from biologically active graft materials and sophisticated implantable systems to high-definition endoscopes and navigation platforms that enable precision procedures. Concurrently, clinical practice is shifting toward less invasive approaches, and health systems are demanding robust evidence of safety, efficacy, and economic value before adoption. These dynamics are reshaping procurement preferences, clinical workflows, and competitive positioning for manufacturers and suppliers.

In parallel, regulatory frameworks and payer expectations are emphasizing real-world outcomes and post-market surveillance, which increases the importance of integrated data capture and longitudinal clinical studies. Investors are responding by favoring companies that demonstrate not only technical differentiation but also reproducible clinical benefits and credible commercialization pathways. As a result, product roadmaps are being designed with modularity and interoperability in mind, anticipating integration with navigation systems, neurostimulation platforms, and digital clinical decision support.

This introduction sets the stage for an analysis that interlinks clinical trends, device innovation, end-user behavior, and broader geopolitical and regulatory shifts. The following sections examine transformative changes in the landscape, tariff-driven operational impacts, segmentation-specific insights, regional dynamics, competitive behaviors, actionable recommendations, research methodology, and concluding implications for leaders shaping the future of neurosurgical care.

Analysis of converging technological innovations, clinical practice shifts, regulatory tightening, and commercial realignments reshaping neurosurgery device development and adoption

The neurosurgery device landscape is undergoing a set of transformative shifts that are simultaneously technological, clinical, regulatory, and commercial. On the technological front, advances in imaging, electromagnetic and optical navigation, and miniaturized endoscopy are enabling surgeons to operate with greater precision and reduced collateral tissue damage. These improvements are complemented by refinements in implant materials and biologic adjuncts designed to enhance bone healing and neural tissue compatibility, thereby improving long-term patient outcomes. Robotic assistance and AI-enabled image guidance are moving from experimental to pragmatic tools that reduce variability and shorten learning curves for complex procedures.

Clinically, the movement toward minimally invasive techniques and outpatient settings is changing procedural mixes and driving demand for instruments and devices that support shorter procedure times and rapid recovery. Neurostimulation technologies, particularly deep brain and vagus nerve stimulation, are expanding indications and seeing renewed interest as understanding of neuromodulation mechanisms deepens. Simultaneously, an increased emphasis on patient-reported outcomes and quality metrics is raising the bar for clinical evidence required to support adoption and reimbursement.

Regulatory and reimbursement landscapes are also shifting, with agencies requiring more comprehensive post-market data and payers looking for demonstrable value in terms of reduced complications, shorter hospital stays, and improved functional outcomes. On the commercial side, partnerships between established medtech firms, specialty device innovators, and clinical research networks are accelerating product translation while changing competitive dynamics. Taken together, these shifts create both opportunities and elevated execution risk for companies that must align product innovation with clinical utility and regulatory rigor.

Evaluation of how tariff-driven cost pressures and supply chain adjustments have reshaped sourcing strategies, product design choices, and commercialization timelines across neurosurgical device makers

The implementation of new tariff measures in the United States during 2025 has prompted a cumulative set of operational and strategic responses across the neurosurgery devices ecosystem. Manufacturers that rely on international supply chains have confronted increased landed costs for components and finished goods, which in turn pressures margin structures and pricing strategies. In response, many organizations initiated near-term tactical measures such as reprioritizing production runs, increasing inventory buffers for critical components, and accelerating dual-source qualification to reduce exposure to single-country supply dependencies. Over a slightly longer horizon, the tariff environment has encouraged a reevaluation of geographic manufacturing footprints, with increased consideration of reshoring or diversification into alternative low-cost manufacturing regions.

Beyond direct cost effects, tariffs have affected partner selection, contract negotiation, and capital allocation decisions. Procurement teams are renegotiating supplier agreements to incorporate tariff pass-through clauses and to obtain more favorable lead times and quality guarantees. Strategic teams are revisiting product designs to simplify bill-of-materials complexity, reduce reliance on tariff-sensitive components, and explore material substitutions that maintain clinical performance while mitigating cost risk. Clinical and regulatory teams are also involved, since design changes can trigger additional validation work and regulatory submissions, thereby affecting time-to-market.

Moreover, the tariff-induced dynamics have had downstream effects on clinical adoption timelines and health system purchasing behavior, as providers factor in potential supply volatility and total cost of ownership when evaluating new devices. Investors and corporate development groups are likewise recalibrating valuation models and partnership timelines to reflect the heightened operational uncertainty. Overall, the cumulative impact of the tariff changes has accelerated supply chain modernization efforts and heightened the importance of resilient, compliant, and clinically focused commercialization strategies.

Segmentation-driven clinical and commercial intelligence linking product subcategories, end-user settings, applications, and procedure types to prioritize innovation and market entry choices

Segmentation analysis reveals nuanced opportunities and execution imperatives across product classes, end users, clinical applications, and procedural approaches. Product type segmentation spans biologics, endoscopes, implantable devices, instruments, navigation systems, and neurostimulators. Within biologics, the focus on bone grafts and growth factors highlights a demand for materials that integrate with host tissue and reduce revision risk, prompting developers to prioritize bioactivity, sterilization compatibility, and supply chain traceability. Endoscopes, differentiated into flexible and rigid designs, show distinct adoption patterns: flexible endoscopes are gaining traction in tortuous anatomy and outpatient procedures, while rigid endoscopes continue to be preferred for certain intracranial and spinal exposures due to image stability. Implantable devices subdivide into cranial and spinal implants, with cranial implants further segmented into cranial plates and dural substitutes and spinal implants emphasizing fusion cages and pedicle screws; insights here underscore the premium on implant biocompatibility, modularity, and ease of fixation to reduce operative time and complication rates. Instruments, encompassing drills and perforators, retractor systems, and ultrasonic aspirators, are being evaluated by clinical teams for ergonomics, sterilization cycles, and compatibility with minimally invasive access. Navigation systems, split between electromagnetic and optical platforms, must deliver registration accuracy and interoperability with imaging suites. Neurostimulators, categorized into deep brain stimulators and vagus nerve stimulators, are advancing through refined lead technologies and closed-loop programming options that support expanded therapeutic indications.

End user segmentation includes ambulatory surgical centers, hospitals, research institutes, and specialty clinics. Ambulatory surgical centers are driving demand for compact, cost-effective devices that enable same-day discharge, whereas hospitals prioritize systems that integrate with existing imaging and monitoring infrastructure and support complex case mixes. Research institutes and specialty clinics serve as early adopters, providing clinical evidence and proof-of-concept data that can accelerate broader adoption.

Application segmentation covers brain tumors, epilepsy, hydrocephalus, movement disorders, pain management, and spinal cord disorders. Each application imposes distinct clinical performance requirements, ranging from precision resection margins for oncologic procedures to long-term stimulation durability for movement and pain indications. Procedure segmentation encompasses endoscopic surgery, laser therapy, minimally invasive surgery, and open surgery, and these procedural contexts determine device form factors, sterilization regimens, and instrument sets. Synthesizing these segmentation lenses highlights where clinical unmet needs intersect with technological capability and where targeted evidence generation and commercialization investments will deliver highest impact.

Comparative regional assessment of clinical infrastructure, regulatory nuance, procurement behavior, and strategic pathways to accelerate adoption across major global territories

Regional dynamics are shaping both opportunity and operational planning, with distinct priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, consolidated health systems and progressive ambulatory surgical center networks are creating demand for devices that demonstrate clear economic and clinical value across diverse care settings. Regulatory pathways in the region are increasingly aligned with post-market evidence expectations, requiring manufacturers to invest in registries and outcomes tracking. The Europe, Middle East & Africa region presents a heterogeneous landscape where reimbursement mechanisms, hospital procurement practices, and clinical infrastructure vary widely; manufacturers seeking traction must tailor market access strategies to national health technology assessment processes and engage local clinical champions to navigate adoption barriers. In the Asia-Pacific region, rapid hospital infrastructure expansion, growing neurosurgical caseloads, and government-led investment in healthcare capacity are driving demand for scalable device solutions and localized manufacturing partnerships. Across all regions, supply chain resilience, regulatory harmonization efforts, and digital integration capabilities are differentiators that influence both purchasing decisions and long-term partnerships.

Transnational considerations further complicate regional strategies. Cross-border clinical trials, regulatory equivalence initiatives, and multiregional reimbursement pilots can accelerate global launches but require careful orchestration of regulatory filings, clinical evidence packages, and training programs. Manufacturers that design regional rollouts to leverage center-of-excellence partnerships, digital training platforms, and adaptive pricing structures are better positioned to translate early clinical uptake into sustained adoption and favorable procurement terms.

Strategic company behaviors and partnership models revealing how integrated platforms, specialty innovators, and contract manufacturing choices influence commercialization and scaling

Company-level behaviors reveal a competitive landscape where established medtech firms, focused device specialists, and innovative startups each play distinct roles in shaping the trajectory of neurosurgical care. Leading firms are investing in platform strategies that bundle hardware, software, and data services to create integrated solutions that lower clinical variability and provide measurable outcomes. At the same time, focused specialists and emerging companies are advancing point innovations-novel biologics, refined implant designs, or next-generation stimulation leads-that address specific clinical gaps and can be attractive targets for partnership or acquisition.

Across the ecosystem, commercialization strategies emphasize evidence generation, clinician training, and service models that support device uptime and clinical outcomes. Strategic partnerships between device manufacturers, imaging and navigation vendors, and academic centers are accelerating product validation and clinician endorsement. Manufacturing partners and contract service providers are also central to scalability, particularly for companies that elect to regionalize production to mitigate tariff and logistics risks. Additionally, firms that prioritize transparent pricing, robust post-market surveillance, and clear interoperability standards are finding smoother pathways into health system procurement processes. In aggregate, company insights point to a bifurcated market where platform incumbents focus on integrated solutions and specialty innovators pursue clinical differentiation, both needing disciplined execution across regulatory, clinical, and commercial dimensions.

Actionable cross-functional guidance for product development, supply resilience, evidence generation, and commercialization to secure durable adoption and competitive advantage

Industry leaders should take a prioritized, cross-functional approach that aligns product innovation with evidence generation, supply resilience, and customer-centric commercialization. First, embed clinical evidence planning early in development cycles so that trials, registries, and real-world data capture address the endpoints that matter to surgeons, payers, and purchasers. This anticipatory approach shortens commercialization timelines and enhances reimbursement positioning. Next, redesign supply chain strategies to reduce single-source exposure and to evaluate regional manufacturing or dual-sourcing where tariff risk or logistics disruption could materially affect time-to-surgery. Investing in supplier qualification and materials engineering can yield durable cost and quality advantages.

Commercially, tailor value propositions to specific end-user segments: ambulatory surgical centers seek compact, cost-effective solutions; hospitals demand interoperability and service reliability; specialty clinics value clinical performance and training. Develop modular platforms and compatible instrument ecosystems to reduce procurement friction and to enable incremental upgrades rather than wholesale replacements. Operationally, expand clinician training programs through digital simulation and proctoring models to accelerate surgeon proficiency and to capture early outcome data. Regulatory and quality teams should prepare for iterative submissions by documenting post-market surveillance plans and by building electronic data capture processes that support compliance with regional requirements.

Finally, pursue alliances that complement internal capabilities, whether for advanced navigation, biologic manufacturing, or clinical research networks. Prioritize commercial pilots with high-impact centers that can produce reproducible outcomes and serve as reference accounts. By executing on these recommendations, leaders can improve the odds of durable adoption and create defensible competitive positioning in a dynamic neurosurgical device landscape.

Transparent mixed-methods research approach integrating practitioner interviews, clinical literature, regulatory review, and scenario analysis to underpin robust conclusions

The findings synthesized in this summary are grounded in a mixed-methods research approach that combined qualitative expert interviews, targeted primary research with clinicians and purchasing leaders, and rigorous secondary analysis of clinical literature and regulatory documentation. Primary inputs included structured interviews with neurosurgeons, operating room managers, hospital procurement specialists, device engineers, and health economics experts to capture both clinical priorities and procurement dynamics. These perspectives were triangulated with peer-reviewed clinical studies, device registries, and public regulatory filings to validate clinical performance claims, safety profiles, and post-market obligations.

Analytical methods included thematic synthesis to identify principal clinical and commercial trends, scenario analysis to evaluate the operational impacts of tariff changes and supply chain disruptions, and segmentation mapping to align device attributes with end-user needs and procedural contexts. Quality assurance protocols ensured that all claims were corroborated by more than one source and that conflicting inputs were reconciled through follow-up interviews or sensitivity checks. Ethical and compliance considerations governed the handling of primary data, and anonymized summaries of interview findings were used to protect confidentiality while preserving the richness of practitioner insight.

This methodological framework supports robust, actionable conclusions by integrating practitioner insight with documentary evidence and by explicitly addressing areas of uncertainty through scenario planning and sensitivity assessment.

Synthesis of strategic imperatives and risk considerations that will determine which organizations succeed in advancing clinical adoption and commercial scale in neurosurgical care

The neurosurgery devices ecosystem sits at an inflection point where technology, clinical demand, regulatory expectations, and geopolitical factors converge to reshape investment and execution priorities. Opportunities are abundant for organizations that can align differentiated device capabilities with rigorous evidence generation, resilient supply chains, and tailored commercialization strategies for specific clinical and regional contexts. Conversely, companies that fail to plan for tariff-induced cost volatility, regulatory rigor, and the increasing demand for demonstrable outcomes risk slower adoption and eroded commercial returns.

Leaders should focus on building interoperable platforms, investing in clinician training and real-world evidence programs, and structuring supply chains to minimize disruption risk. Strategic partnerships and targeted M&A can accelerate access to complementary technologies and clinical channels, while prudent product design choices can reduce total cost of ownership for providers. Ultimately, success in this market will favor organizations that take a systems-thinking approach, integrating engineering excellence with clinical validation and adaptive commercialization models that reflect the realities of care delivery across regions and provider types.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of robotic-assisted neurosurgical platforms for precision tumor resection
  • 5.2. Rising demand for minimally invasive endoscopic tools in spinal neurosurgery procedures
  • 5.3. Integration of AI powered imaging systems for real time intraoperative navigation
  • 5.4. Development of biocompatible neural implants for chronic deep brain stimulation therapy
  • 5.5. Advances in optogenetic neuromodulation devices for targeted neural circuit regulation
  • 5.6. Growth of portable intraoperative MRI systems to enhance operating room efficiency
  • 5.7. Expansion of wireless wearable sensors for continuous postoperative neurological monitoring

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurosurgery Devices Market, by Product Type

  • 8.1. Biologics
    • 8.1.1. Bone Grafts
    • 8.1.2. Growth Factors
  • 8.2. Endoscopes
    • 8.2.1. Flexible Endoscopes
    • 8.2.2. Rigid Endoscopes
  • 8.3. Implantable Devices
    • 8.3.1. Cranial Implants
      • 8.3.1.1. Cranial Plates
      • 8.3.1.2. Dural Substitutes
    • 8.3.2. Spinal Implants
      • 8.3.2.1. Fusion Cages
      • 8.3.2.2. Pedicle Screws
  • 8.4. Instruments
    • 8.4.1. Drills And Perforators
    • 8.4.2. Retractor Systems
    • 8.4.3. Ultrasonic Aspirators
  • 8.5. Navigation Systems
    • 8.5.1. Electromagnetic Systems
    • 8.5.2. Optical Systems
  • 8.6. Neurostimulators
    • 8.6.1. Deep Brain Stimulators
    • 8.6.2. Vagus Nerve Stimulators

9. Neurosurgery Devices Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Hospitals
  • 9.3. Research Institutes
  • 9.4. Specialty Clinics

10. Neurosurgery Devices Market, by Application

  • 10.1. Brain Tumors
  • 10.2. Epilepsy
  • 10.3. Hydrocephalus
  • 10.4. Movement Disorders
  • 10.5. Pain Management
  • 10.6. Spinal Cord Disorders

11. Neurosurgery Devices Market, by Procedure

  • 11.1. Endoscopic Surgery
  • 11.2. Laser Therapy
  • 11.3. Minimally Invasive Surgery
  • 11.4. Open Surgery

12. Neurosurgery Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurosurgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurosurgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Medtronic plc
    • 15.3.2. Stryker Corporation
    • 15.3.3. Johnson & Johnson
    • 15.3.4. B. Braun Melsungen AG
    • 15.3.5. Zimmer Biomet Holdings, Inc.
    • 15.3.6. Abbott Laboratories
    • 15.3.7. Boston Scientific Corporation
    • 15.3.8. Integra LifeSciences Holdings Corporation
    • 15.3.9. Penumbra, Inc.
    • 15.3.10. Globus Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NEUROSURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NEUROSURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEUROSURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA NEUROSURGERY DEVICES MARKE